Do we measure or compute polygenic risk scores? Why language matters

被引:0
|
作者
Bart Penders
A. Cecile J. W. Janssens
机构
[1] Maastricht University,Care and Public Health Research Institute
[2] Emory University,Department of Epidemiology, Rollins School of Public Health
来源
Human Genetics | 2022年 / 141卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Here, we argue that polygenic risk scores (PRSs) are different epistemic objects as compared to other biomarkers such as blood pressure or sodium level. While the latter two may be subject to variation, measured inaccurately or interpreted in various ways, blood flow has pressure and sodium is available in a concentration that can be quantified and visualised. In stark contrast, PRSs are calculated, compiled or constructed through the statistical assemblage of genetic variants. How researchers frame and name PRSs has consequences for how we interpret and value their results. We distinguish between the tangible and inferential understanding of PRS and the corresponding languages of measurement and computation, respectively. The conflation of these frames obscures important questions we need to ask: what PRS seeks to represent, whether current ways of ‘doing PRS’ are optimal and responsible, and upon what we base the credibility of PRS-based knowledge claims.
引用
收藏
页码:1093 / 1097
页数:4
相关论文
共 50 条
  • [1] Do we measure or compute polygenic risk scores? Why language matters
    Penders, Bart
    Janssens, A. Cecile J. W.
    [J]. HUMAN GENETICS, 2022, 141 (05) : 1093 - 1097
  • [2] Polygenic risk scores: where do we stand?
    de La Harpe, Roxane
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (13) : 1380 - 1381
  • [3] DO WE MEASURE WHAT MATTERS TO PATIENTS AND WHY? Reply
    Cerfolio, Robert James
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (06): : 2757 - 2758
  • [4] How and why do we measure surgical risk?
    Chand, Manish
    Armstrong, Tom
    Britton, Greg
    Nash, Guy F.
    [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2007, 100 (11) : 508 - 512
  • [5] How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management?
    Hadley, Trevor D.
    Agha, Ali M.
    Ballantyne, Christie M.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (06)
  • [6] Why Do We Measure?
    Whistler, Art
    [J]. MANUFACTURING ENGINEERING, 2009, 143 (03): : 12 - 12
  • [7] Why we need to measure uncertainty (and why we do not do it)
    Harris, R.
    [J]. Environmental Engineering, 2001, 14 (04) : 56 - 58
  • [8] How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management?
    Trevor D. Hadley
    Ali M. Agha
    Christie M. Ballantyne
    [J]. Current Atherosclerosis Reports, 2021, 23
  • [9] Why what we do matters
    Elnicki, M
    [J]. AMERICAN JOURNAL OF MEDICINE, 2001, 110 (08): : 676 - 680
  • [10] Validity of polygenic risk scores: are we measuring what we think we are?
    Janssens, A. Cecile J. W.
    [J]. HUMAN MOLECULAR GENETICS, 2019, 28 (R2) : R143 - R150